ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0374

The BASDAI Index During Pregnancy

Olga Krichevskaya, Tatiana Dubinina, Ekaterina Ilinih, Svetlana Glukhova, Anastasia Demina and Irina Andrianova, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia

Meeting: ACR Convergence 2022

Keywords: Ankylosing spondylitis (AS), Back pain, Disease Activity, Morning Stiffness, pregnancy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: During pregnancy, BASDAI may reflect not only the activity of ankylosing spondylitis (AS), but also back pain and fatigue, that are associated with the pregnancy itself. Our objective wasto identify BASDAI components with the most optimal ratio of sensitivity and specificity to assess the activity of AS during pregnancy.

Methods: The study group included 50 pregnant women with AS (modified New York criteria, 1984). Mean age of patients was 31,6±4,2 years, and disease duration – 132,4±85,8 months. Additionally, 90 healthy pregnant women with no history of back pain and arthritis were surveyed, the average age in this group was 27,9±6,4 years. Of these, 51 women who were included in the control group had back pain in at least one trimester.

Control visits were scheduled at 10-11, 20-21, and 31-32 weeks of pregnancy. At each visit, all the women filled out the BASDAI. A ROC-analysis was performed with the calculation of the area under the curve (AUC) of each BASDAI component in each trimester of pregnancy.

Results: The AUC value for BASDAI in the 1st trimester was 0,74; the AUC of all BASDAI components exceeded 0,5 with a maximum value for the severity and duration of morning stiffness – 0,9 and 0,8, respectively, and with a minimum value for fatigue and back pain – 0,6 in each case. In the 2nd and 3rd trimesters, the AUC values for fatigue and back pain were less than 0,5, the AUC of morning stiffness components remained 0,8.

Conclusion: Morning stiffness has the highest classification value during pregnancy. Back pain and fatigue in the second half of pregnancy and BASDAI itself in the 3rd trimester are not sufficiently informative
for assessing the activity of AS.

Supporting image 1


Disclosures: O. Krichevskaya, None; T. Dubinina, None; E. Ilinih, None; S. Glukhova, None; A. Demina, None; I. Andrianova, None.

To cite this abstract in AMA style:

Krichevskaya O, Dubinina T, Ilinih E, Glukhova S, Demina A, Andrianova I. The BASDAI Index During Pregnancy [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-basdai-index-during-pregnancy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-basdai-index-during-pregnancy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology